# Sangoma Technologies Corp: financial statements, quarterly

SANG · Nasdaq · CIK 1753368 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/sang.md) · [Financials](/companies/sang/financials.md) · [Filings](/companies/sang/filings.md) · [Insiders](/companies/sang/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sang/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2020-06-30) | period not labelled (2021-06-30) | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.0](/filings/0001104659-22-103136.md) | [22.1](/filings/0001753368-23-000020.md) | [12.7](/filings/0001753368-24-000014.md) | [11.2](/filings/0001753368-25-000018.md) | [16.2](/filings/0001753368-25-000018.md) | [13.5](/filings/0001753368-25-000018.md) |
| Current assets | $m | [39.7](/filings/0001104659-22-103136.md) | [53.3](/filings/0001104659-22-103136.md) | [60.3](/filings/0001753368-23-000020.md) | [61.9](/filings/0001753368-24-000014.md) | [57.1](/filings/0001753368-25-000018.md) | [42.6](/filings/0001753368-25-000018.md) |
| Total assets | $m | not reported | not reported | [499](/filings/0001753368-23-000020.md) | [443](/filings/0001753368-24-000014.md) | [401](/filings/0001753368-25-000018.md) | [347](/filings/0001753368-25-000018.md) |
| Current liabilities | $m | [36.5](/filings/0001104659-22-103136.md) | [55.2](/filings/0001104659-22-103136.md) | [78.4](/filings/0001753368-23-000020.md) | [63.5](/filings/0001753368-24-000014.md) | [60.1](/filings/0001753368-25-000018.md) | [49.5](/filings/0001753368-25-000018.md) |
| Total liabilities | $m | not reported | not reported | [205](/filings/0001753368-23-000020.md) | [177](/filings/0001753368-24-000014.md) | [141](/filings/0001753368-25-000018.md) | [92.4](/filings/0001753368-25-000018.md) |
| Shareholders' equity | $m | [54.9](/filings/0001104659-22-103136.md) | [376](/filings/0001104659-22-103136.md) | [294](/filings/0001753368-23-000020.md) | [266](/filings/0001753368-24-000014.md) | [260](/filings/0001753368-25-000018.md) | [254](/filings/0001753368-25-000018.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 33,338,932 at 2026-06-30, from the cover of the [40-F filed 2026-09-28](/filings/0001753368-26-000011.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.